×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call Transcript
Yahoo Finance
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call Transcript March 5, 2024 TRACON Pharmaceuticals, Inc. beats earnings...
2 months ago
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Lowered by StockNews.com
Defense World
Read TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Lowered by StockNews.com at Defense World.
1 day ago
Tracon stock drops on data for cancer drug (NASDAQ:TCON)
Seeking Alpha
Tracon Pharmaceuticals (TCON) stock plunges as early data from its ENVASARC Phase 2 trial for cancer drug envafolimab disappoints.
1 month ago
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment
GlobeNewswire
SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company...
5 months ago
Pharma Co. May Have Accelerated FDA Approval in 2024 Research Report
Streetwise Reports
TRACON Pharmaceuticals Inc. provided an update on enrollment progress for their ongoing Phase 2 ENVASARC clinical trial testing the drug...
4 months ago
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
Yahoo Finance
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company...
6 days ago
Tracon Pharma (NASDAQ: TCON) up 58% - it might, actually, have something to sell
Dhaka Tribune
Tracon Pharmaceuticals (NASDAQ: TCON) stock is up 58% this morning. That might be a bit much but there is something interesting going on in...
5 months ago
TRACON Pharmaceuticals (TCON) to Release Earnings on Tuesday
Defense World
TRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on...
1 day ago
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company...
6 months ago
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent ...
Yahoo Finance
ENVASARC Trial is Fully Enrolled and Final Data are Expected in Third Quarter 2024 SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- TRACON...
1 month ago